文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

用于靶向降解细胞膜蛋白的带可替换夹钳的DNA镊子。

DNA Tweezers with Replaceable Clamps for the Targeted Degradation of Cell Membrane Proteins.

作者信息

Sun Yang, Huang Yichen, Chen Daiquan, Hu Shangjiu, Pan Tao, Liu Yuanding, Wang Ruowen, Tan Weihong

机构信息

Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), The Chinese Academy of Sciences, Hangzhou 310022, China.

出版信息

Pharmaceutics. 2025 Jun 17;17(6):785. doi: 10.3390/pharmaceutics17060785.


DOI:10.3390/pharmaceutics17060785
PMID:40574098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12197088/
Abstract

: Cell membrane proteins play crucial roles in signal transduction and nutrient transport. Many membrane proteins are reportedly overexpressed in cancer cells, which is closely related to cancer progression. The targeted degradation of these membrane proteins has been demonstrated to be a promising strategy for tumor treatment. Several strategies using aptamers to mediate membrane protein lysis, such as lysosomal-mediated lysis and proteasome-mediated lysis, have been reported, but their efficiency is limited by the binding affinity of the aptamer to a single target. : We constructed DNA tweezers with replaceable clamps, which can lyse different proteins upon clamp replacement. Moreover, the clamp improved the degradation efficiency of the target proteins by enhancing the specificity and improving the binding affinity. : Lysis was verified in different tumor cell lines and the antitumor activity was confirmed in zebrafish. : Overall, these DNA tweezers improve the efficiency of the targeted delivery of functional nucleic acids, provide an efficient and versatile strategy for the degradation of disease-causing proteins, and expand the approach to antitumor therapy.

摘要

细胞膜蛋白在信号转导和营养物质运输中发挥着关键作用。据报道,许多膜蛋白在癌细胞中过度表达,这与癌症进展密切相关。这些膜蛋白的靶向降解已被证明是一种有前景的肿瘤治疗策略。已经报道了几种使用适配体介导膜蛋白裂解的策略,如溶酶体介导的裂解和蛋白酶体介导的裂解,但它们的效率受到适配体与单一靶点结合亲和力的限制。我们构建了具有可替换夹子的DNA镊子,其在夹子替换后可裂解不同的蛋白质。此外,夹子通过增强特异性和提高结合亲和力提高了靶蛋白的降解效率。在不同的肿瘤细胞系中验证了裂解,并在斑马鱼中证实了其抗肿瘤活性。总体而言,这些DNA镊子提高了功能性核酸靶向递送的效率,为致病蛋白的降解提供了一种高效且通用的策略,并扩展了抗肿瘤治疗的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/11aebd81c8d0/pharmaceutics-17-00785-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/12d4c4294bfb/pharmaceutics-17-00785-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/5b8802a056aa/pharmaceutics-17-00785-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/c5c38e9f6086/pharmaceutics-17-00785-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/722fb390922c/pharmaceutics-17-00785-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/5b729e3e8ec7/pharmaceutics-17-00785-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/3294f00757ed/pharmaceutics-17-00785-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/11aebd81c8d0/pharmaceutics-17-00785-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/12d4c4294bfb/pharmaceutics-17-00785-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/5b8802a056aa/pharmaceutics-17-00785-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/c5c38e9f6086/pharmaceutics-17-00785-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/722fb390922c/pharmaceutics-17-00785-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/5b729e3e8ec7/pharmaceutics-17-00785-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/3294f00757ed/pharmaceutics-17-00785-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c103/12197088/11aebd81c8d0/pharmaceutics-17-00785-g006.jpg

相似文献

[1]
DNA Tweezers with Replaceable Clamps for the Targeted Degradation of Cell Membrane Proteins.

Pharmaceutics. 2025-6-17

[2]
Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018-2-6

[3]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Health Technol Assess. 2001

[4]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2021-4-19

[5]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2020-1-9

[6]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

[7]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[8]
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Cochrane Database Syst Rev. 2017-12-22

[9]
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.

Cochrane Database Syst Rev. 2001

[10]
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.

Respir Res. 2024-12-21

本文引用的文献

[1]
DNA Tetrahedron-Driven Multivalent Proteolysis-Targeting Chimeras: Enhancing Protein Degradation Efficiency and Tumor Targeting.

J Am Chem Soc. 2025-1-15

[2]
Development of Integrin-Facilitated Bispecific Aptamer Chimeras for Membrane Protein Degradation.

J Am Chem Soc. 2024-9-18

[3]
Securing LYTAC with Logic-Identification System for Cancer Cell-Selective Membrane Protein Degradation.

Small. 2024-7

[4]
Insulin-like Growth Factor 2-Tagged Aptamer Chimeras (ITACs) Modular Assembly for Targeted and Efficient Degradation of Two Membrane Proteins.

Angew Chem Int Ed Engl. 2024-1-25

[5]
Covalent LYTAC Enabled by DNA Aptamers for Immune Checkpoint Degradation Therapy.

J Am Chem Soc. 2023-11-1

[6]
Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras.

Science. 2023-10-20

[7]
Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review).

Int J Mol Med. 2023-9

[8]
The grading quality markers identification of Panax notoginseng under the guidance of traditional experience using untargeted metabolomics and anti-myocardial ischemia evaluation of zebrafish.

Phytomedicine. 2023-3

[9]
Bispecific Aptamer-Based Recognition-then-Conjugation Strategy for PD1/PDL1 Axis Blockade and Enhanced Immunotherapy.

ACS Nano. 2022-12-27

[10]
A multi-storey DNA nanostructure containing doxorubicin and AS1411 aptamer for targeting breast cancer cells.

J Drug Target. 2022-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索